Abstract:Objective: Cure models are frequently used in survival analysis to account for a cured fraction in the data. When there is a cure rate present, researchers often prefer cure models over parametric models to analyse the survival data. These models enable the ability to define the probability distribution of survival durations for patients who are at risk. Various distributions can be considered for the survival times, such as Exponentiated Weibull Exponential (EWE), Exponential Exponential (EE), Weibull and lognormal distribution. The objective of this research is to choose the most appropriate distribution that accurately represents the survival times of patients who have not been cured. This will be accomplished by comparing various non-mixture cure models that are based on the EWE distribution with its sub-distributions, and distributions distinct from those belonging to the EWE distribution family. Material and methods: A sample of 85 patients diagnosed with superficial bladder tumours was selected to be used in fitting the non-mixture cure model. In order to estimate the parameters of the suggested model, which takes into account the presence of a cure rate, censored data, and covariates, we utilized the maximum likelihood estimation technique using R software version 3.5.7. Result: Upon conducting a comparison of various parametric models fitted to the data, both with and without considering the cure fraction and without incorporating any predictors, the EE distribution yields the lowest AIC, BIC, and HQIC values among all the distributions considered in this study, (1191.921/1198.502, 1201.692/1203.387, 1195.851/1200.467). Furthermore, when considering a non-mixture cure model utilizing the EE distribution along with covariates, an estimated ratio was obtained between the probabilities of being cured for placebo and thiotepa groups (and its 95% confidence intervals) were 0.76130 (0.13914, 6.81863). Conclusion: The findings of this study indicate that EE distribution is the optimal selection for determining the duration of survival in individuals diagnosed with bladder cancer.

Cure models with adaptive activation for modeling cancer survival

Generalized parametric cure models for relative survival

Partly linear single-index cure models with a nonparametric incidence link function

A Bayesian promotion time cure model with current status data

A new latent cure rate marker model for survival data

A New Mixture Model With Cure Rate Applied to Breast Cancer Data

Estimand-based Inference in Presence of Long-Term Survivors

Modeling excess hazard with time--to--cure as a parameter

Likelihood-Based Inference for Semi-Parametric Transformation Cure Models with Interval Censored Data

Causal Inference for Time-to-event Data with a Cured Subpopulation.

Statistical Inference on the Cure Time

Nonparametric covariate hypothesis tests for the cure rate in mixture cure models

A multiple imputation approach to distinguish curative from life-prolonging effects in the presence of missing covariates

On semiparametric transformation cure models

Non-Mixture Cure Model Estimation in Bladder Cancer Patients: A Novel Approach with Exponentiated Weibull Exponential Distribution

A Multivariate Cure Model for Left- and Right-Censored Data with Application to Colorectal Cancer Screening Patterns

Efficient auxiliary information synthesis for cure rate model

A semiparametric accelerated failure time-based mixture cure tree

A Support Vector Machine Based Cure Rate Model For Interval Censored Data

A functional proportional hazard cure rate model for interval-censored data

A Weibull Mixture Cure Frailty Model for High-dimensional Covariates